Pathstone Holdings’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.1M Buy
342,369
+78,790
+30% +$7.19M 0.09% 156
2026
Q1
$27.1M Sell
263,579
-3,307
-1% -$373K 0.11% 140
2025
Q4
$33.4M Sell
266,886
-1,910
-0.7% -$243K 0.13% 117
2025
Q3
$36M Sell
268,796
-2,831
-1% -$372K 0.14% 101
2025
Q2
$36.9M Buy
271,627
+6,302
+2% +$831K 0.15% 94
2025
Q1
$35.2M Buy
265,325
+5,814
+2% +$740K 0.15% 103
2024
Q4
$29.4M Sell
259,511
-2,863
-1% -$331K 0.13% 107
2024
Q3
$29.9M Buy
262,374
+9,401
+4% +$1.03M 0.13% 115
2024
Q2
$26.3M Buy
252,973
+2,175
+0.9% +$231K 0.12% 125
2024
Q1
$28.5M Buy
250,798
+34,198
+16% +$3.92M 0.13% 111
2023
Q4
$23.9M Buy
+216,600
New +$21.6M 0.13% 112

Other funds holding ABT

Pathstone Holdings's ABT Position: Q2 2026 in Review

Pathstone Holdings increased its Abbott (ABT) stake by 30% in Q2 2026, buying an estimated $7.19M and bringing the position to 342,369 shares worth $31.1M. The position accounts for 0.09% of the portfolio, ranked #156.

Pathstone Holdings first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $36.9M in Q2 2025. 2,950 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Pathstone Holdings held 342,369 shares of Abbott worth $31.1M as of Q2 2026.
  • Pathstone Holdings bought 78,790 Abbott shares in Q2 2026, an estimated $7.19M.
  • Abbott made up 0.09% of Pathstone Holdings's portfolio in Q2 2026, its #156 holding.
  • Pathstone Holdings first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Abbott position peaked at $36.9M in Q2 2025.
  • 2,950 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.